Cycloaliphatic aminosulfonic acid derivatives

Abstract

New aminosulfonic acids of the general formula I ##STR1## wherein n represents the figures 4, 5, or 6, prepared according to previously known processes and characterized by very good tolerance and valuable cardiovascular properties, serve for the therapy of dysrhythmia and are superior to procaine.

We claim: 
     
       1. An aminosulfonic acid of the general formula I ##STR5## wherein n is 4, 5, or 6. 
     
     
       2. 1-Aminomethylcyclohexylmethanesulfonic acid. 
     
     
       3. A method for treating cardiovascular diseases comprising administering to a host suffering therefrom an effective amount of a compound according to claim 1 in unit dosage form. 
     
     
       4. The method of claim 3 wherein an effective amount of 1-aminomethylcyclohexylmethanesulfonic is used in unit dosage form. 
     
     
       5. A pharmaceutical preparation for treating cardiovascular diseases comprising an effective amount of a compound according to claim 1 together with a pharmacologically acceptable carrier. 
     
     
       6. A preparation according to claim 5 containing an effective amount of 1-aminomethylcyclohexylmethanesulfonic acid.